Jarrad Mattieu Aguirre

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 1 sale

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€3,247

Latest filing published 13 Oct 2026 for Lyell Immunopharma, Inc., €3,247. Read the official filing

Filing timeline

BuySale

Jarrad Mattieu Aguirre

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Jarrad Mattieu Aguirre: trading record in brief

Our data holds just one disclosure by Jarrad Mattieu Aguirre, dated 13 October 2026, reporting an open-market sale worth €3,247 in Lyell Immunopharma, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.